AU2003229769A1 - Multifunctional polyethylene glycol derivatives: preparation and use - Google Patents

Multifunctional polyethylene glycol derivatives: preparation and use

Info

Publication number
AU2003229769A1
AU2003229769A1 AU2003229769A AU2003229769A AU2003229769A1 AU 2003229769 A1 AU2003229769 A1 AU 2003229769A1 AU 2003229769 A AU2003229769 A AU 2003229769A AU 2003229769 A AU2003229769 A AU 2003229769A AU 2003229769 A1 AU2003229769 A1 AU 2003229769A1
Authority
AU
Australia
Prior art keywords
preparation
polyethylene glycol
glycol derivatives
multifunctional polyethylene
multifunctional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003229769A
Inventor
Maurizio Ballico
Gian Maria Bonora
Sara Drioli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universita degli Studi di Trieste
Original Assignee
Universita degli Studi di Trieste
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universita degli Studi di Trieste filed Critical Universita degli Studi di Trieste
Publication of AU2003229769A1 publication Critical patent/AU2003229769A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00—Applications
    • C08L2203/02—Applications for biomedical use
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polyethers (AREA)
  • Medicinal Preparation (AREA)
AU2003229769A 2002-05-06 2003-05-02 Multifunctional polyethylene glycol derivatives: preparation and use Abandoned AU2003229769A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2002A000951 2002-05-06
IT2002MI000951A ITMI20020951A1 (en) 2002-05-06 2002-05-06 MULTIFUNCTIONAL DERIVATIVES OF POLYETHYLENGLICLE THEIR PREPARATION AND USE
PCT/EP2003/004620 WO2003093346A1 (en) 2002-05-06 2003-05-02 Multifunctional polyethylene glycol derivatives: preparation and use

Publications (1)

Publication Number Publication Date
AU2003229769A1 true AU2003229769A1 (en) 2003-11-17

Family

ID=11449835

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003229769A Abandoned AU2003229769A1 (en) 2002-05-06 2003-05-02 Multifunctional polyethylene glycol derivatives: preparation and use

Country Status (3)

Country Link
AU (1) AU2003229769A1 (en)
IT (1) ITMI20020951A1 (en)
WO (1) WO2003093346A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008509692A (en) * 2004-08-16 2008-04-03 ノボ ノルディスク アクティーゼルスカブ Peptide multimers
CU23556A1 (en) * 2005-11-30 2010-07-20 Ct Ingenieria Genetica Biotech POLYMER STRUCTURE SIMILAR TO DENDRÍMERO FOR THE OBTAINING OF CONJUGATES OF PHARMACEUTICAL INTEREST
RU2009114154A (en) * 2006-09-15 2010-10-20 Энзон Фармасьютикалз, Инк. (Us) POLYMERIC DRUGS WITH DIRECTED DELIVERY CONTAINING POLYFUNCTIONAL LINKERS
EP1955712A1 (en) * 2007-02-09 2008-08-13 Scil proteins GmbH Multimeric conjugate
US11725073B2 (en) 2020-12-29 2023-08-15 Hongene Biotech Corporation Compositions and methods for liquid phase oligonucleotide synthesis
US11851454B2 (en) 2021-12-30 2023-12-26 Hongene Biotech Corporation Compositions and methods for liquid phase oligonucleotide synthesis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643575A (en) * 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
US5932462A (en) * 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
CA2313225A1 (en) * 1997-12-12 1999-06-17 Macromed, Inc. Heterofunctionalized star-shaped poly(ethylene glycols) for protein modification

Also Published As

Publication number Publication date
ITMI20020951A1 (en) 2003-11-06
WO2003093346A1 (en) 2003-11-13
ITMI20020951A0 (en) 2002-05-06

Similar Documents

Publication Publication Date Title
AU2003266321A1 (en) Tetrahydropyrimidine-2-one derivatives and their uses
AU2003252478A1 (en) Ccr4 antagonist and medicinal use thereof
AU2001277754A1 (en) Proline derivatives and use thereof as drugs
AU2003214945A1 (en) Multi-function catheter and use thereof
AU2003249909A1 (en) Phenoxypropenylphenyl derivatives and their use as herbicides
AU2003303388A1 (en) Triptolide derivatives and their use
AU2002364051A1 (en) Anti-cancer combination and use thereof
AU2002354476A1 (en) Pyrazolopyridine derivatives and medicinal use thereof
AU2003255645A1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
AU2003268771A1 (en) Cosmetic pack preparation
AU2003213345A1 (en) Cosmetic preparation
AU2002950853A0 (en) Aminopyrimidine compound and pharmaceutical use thereof
AU2003269018A1 (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
AU2003296369A1 (en) Imminoamines and preparation thereof
AU2003205558A1 (en) Thioibotenic acid and derivatives thereof
AU2003255463A1 (en) Substituted isoxazole derivatives and their use in pharmaceutics
AU2002343103A1 (en) Aminoalkylimidazole derivatives and their use in medicine
AU2002308891A1 (en) Novel heterocyclic derivatives and medicinal use thereof
AU2003229769A1 (en) Multifunctional polyethylene glycol derivatives: preparation and use
AU2003281691A1 (en) Furoisoquinoline derivative and use thereof
AU2003272423A1 (en) Centrosome proteins and uses thereof
AU2002308889A1 (en) Novel heterocyclic compound and medicinal use thereof
AU2003284460A1 (en) Medicinal composition
AU2003207628A1 (en) Structural and cytoskeleton-associated proteins
AU2003900495A0 (en) Aroylhydrazone derivatives and therapeutic uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase